CDMOs Redefine Pharma Supply Chains with AI, Cold-Chain Logistics and Smart Sourcing
In a recent episode of BioSpace’s Denatured podcast, host Jennifer Smith-Parker talks with Arvind Singh, vice-president and global head of supply chain at SK Pharmteco. The discussion is presented in partnership with SK Pharmteco.
The conversation focuses on how contract development and manufacturing organisations are changing supply-chain strategies to support a new generation of complex modalities such as cell and gene therapies.
Key topics include smarter raw-material sourcing, precision cold-chain logistics, navigating geopolitical uncertainty, and using artificial intelligence to build sustainable and scalable clinical and commercial capabilities.
The guests note that the views expressed are their own and do not represent their companies.
This writeup was produced by pharmadog from original reporting by BioSpace.
Original headline: “The supply chain fault lines of modern pharma”
read at BioSpace ↗
comments(0)
5-min edit window · permanent after that